Previous Close | 0.8148 |
Open | 0.8200 |
Bid | 0.7700 x 800 |
Ask | 0.9000 x 1300 |
Day's Range | 0.8151 - 0.8212 |
52 Week Range | 0.8000 - 3.9200 |
Volume | |
Avg. Volume | 65,778 |
Market Cap | 6.082M |
Beta (5Y Monthly) | 1.69 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.4650 |
Earnings Date | May 08, 2023 - May 12, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 6.00 |
Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today reported results for the fourth quarter and full year ended December 31, 2022.
Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced that it will release its financial results for the fourth quarter and full year 2022 after the close of trading on Wednesday, March 15, 2023.